{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:52:17Z","timestamp":1772916737932,"version":"3.50.1"},"reference-count":43,"publisher":"Japanese Society of Toxicology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2023]]},"DOI":"10.2131\/jts.48.47","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T22:10:12Z","timestamp":1672870212000},"page":"47-56","source":"Crossref","is-referenced-by-count":3,"title":["Establishment of an &lt;i&gt;in vitro&lt;\/i&gt; cholestasis risk assessment system using two-dimensional cultured HepaRG cells and 12 bile acids"],"prefix":"10.2131","volume":"48","author":[{"given":"Toshihisa","family":"Koga","sequence":"first","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Umehara","sequence":"additional","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"Aleo, M.D., Luo, Y., Swiss, R., Bonin, P.D., Potter, D.M. and Will, Y. (2014): Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology, <b>60<\/b>, 1015-1022.","DOI":"10.1002\/hep.27206"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Burbank, M.G., Sharanek, A., Burban, A., Mialanne, H., Aerts, H., Guguen-Guillouzo, C., Weaver, R.J. and Guillouzo, A. (2017): From the cover: mechanistic insights in cytotoxic and cholestatic potential of the endothelial receptor antagonists using HepaRG cells. Toxicol. Sci., <b>157<\/b>, 451-464.","DOI":"10.1093\/toxsci\/kfx062"},{"key":"3","doi-asserted-by":"crossref","unstructured":"De Bruyn, T., Chatterjee, S., Fattah, S., Keemink, J., Nicola\u00ef, J., Augustijns, P. and Annaert, P. (2013): Sandwich-cultured hepatocytes: utility for <i>in vitro<\/i> exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity. Expert Opin. Drug Metab. Toxicol., <b>9<\/b>, 589-616.","DOI":"10.1517\/17425255.2013.773973"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Deferm, N., De Vocht, T., Qi, B., Van Brantegem, P., Gijbels, E., Vinken, M., de Witte, P., Bouillon, T. and Annaert, P. (2019): Current insights in the complexities underlying drug-induced cholestasis. Crit. Rev. Toxicol., <b>49<\/b>, 520-548.","DOI":"10.1080\/10408444.2019.1635081"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Fattinger, K., Funk, C., Pantze, M., Weber, C., Reichen, J., Stieger, B. and Meier, P.J. (2001): The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin. Pharmacol. Ther., <b>69<\/b>, 223-231.","DOI":"10.1067\/mcp.2001.114667"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Gatfield, J., Mueller Grandjean, C., Sasse, T., Clozel, M. and Nayler, O. (2012): Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells. PLoS One, <b>7<\/b>, e47662.","DOI":"10.1371\/journal.pone.0047662"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Gijbels, E., Vilas-Boas, V., Deferm, N., Devisscher, L., Jaeschke, H., Annaert, P. and Vinken, M. (2019): Mechanisms and <i>in vitro<\/i> models of drug-induced cholestasis. Arch. Toxicol., <b>93<\/b>, 1169-1186.","DOI":"10.1007\/s00204-019-02437-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F. and Guguen-Guillouzo, C. (2007): The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem. Biol. Interact., <b>168<\/b>, 66-73.","DOI":"10.1016\/j.cbi.2006.12.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Humbert, L., Maubert, M.A., Wolf, C., Duboc, H., Mah\u00e9, M., Farabos, D., Seksik, P., Mallet, J.M., Trugnan, G., Masliah, J. and Rainteau, D. (2012): Bile acid profiling in human biological samples: comparison of extraction procedures and application to normal and cholestatic patients. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., <b>899<\/b>, 135-145.","DOI":"10.1016\/j.jchromb.2012.05.015"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Kakutani, N., Nanayama, T. and Nomura, Y. (2019): Novel risk assessment of reactive metabolites from discovery to clinical stage. J. Toxicol. Sci., <b>44<\/b>, 201-211.","DOI":"10.2131\/jts.44.201"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kanebratt, K.P. and Andersson, T.B. (2008): HepaRG cells as an <i>in vitro<\/i> model for evaluation of cytochrome P450 induction in humans. Drug Metab. Dispos., <b>36<\/b>, 137-145.","DOI":"10.1124\/dmd.107.017418"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kawaguchi, M., Nukaga, T., Sekine, S., Takemura, A., Susukida, T., Oeda, S., Kodama, A., Hirota, M., Kouzuki, H. and Ito, K. (2020): Mechanism-based integrated assay systems for the prediction of drug-induced liver injury. Toxicol. Appl. Pharmacol., <b>394<\/b>, 114958.","DOI":"10.1016\/j.taap.2020.114958"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Lee, W.M. (2013): Drug-induced acute liver failure. Clin. Liver Dis., <b>17<\/b>, 575-586. viii.","DOI":"10.1016\/j.cld.2013.07.001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Lee, W.T., Kirkham, N., Johnson, M.K., Lordan, J.L., Fisher, A.J. and Peacock, A.J. (2011): Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension. Eur. Respir. J., <b>37<\/b>, 472-474.","DOI":"10.1183\/09031936.00091610"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Le Vee, M., Jigorel, E., Glaise, D., Gripon, P., Guguen-Guillouzo, C. and Fardel, O. (2006): Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line. Eur. J. Pharm. Sci., <b>28<\/b>, 109-117.","DOI":"10.1016\/j.ejps.2006.01.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Lin, Z. and Will, Y. (2012): Evaluation of drugs with specific organ toxicities in organ-specific cell lines. Toxicol. Sci., <b>126<\/b>, 114-127.","DOI":"10.1093\/toxsci\/kfr339"},{"key":"17","unstructured":"Liu, A.J., Ling, F., Wang, D., Wang, Q., L\u00fc, X.D. and Liu, Y.L. (2011): Fasudil inhibits platelet-derived growth factor-induced human pulmonary artery smooth muscle cell proliferation by up-regulation of p27kip<sup>1<\/sup> via the ERK signal pathway. Chin. Med. J. (Engl.), <b>124<\/b>, 3098-3104."},{"key":"18","unstructured":"LiverTox. Database (2022): Clinical and research information on drug-induced liver injury. National institute of diabetes and digestive and kidney diseases, 2012. LiverTox database. (Updated 20 October 2022). Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547852\/"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Molina-Jimenez, F., Benedicto, I., Dao Thi, V.L., Gondar, V., Lavillette, D., Marin, J.J., Briz, O., Moreno-Otero, R., Aldabe, R., Baumert, T.F., Cosset, F.L., Lopez-Cabrera, M. and Majano, P.L. (2012): Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle. Virology, <b>425<\/b>, 31-39.","DOI":"10.1016\/j.virol.2011.12.021"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Morgan, R.E., van Staden, C.J., Chen, Y., Kalyanaraman, N., Kalanzi, J., Dunn, R.T. 2nd, Afshari, C.A. and Hamadeh, H.K. (2013): A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol. Sci., <b>136<\/b>, 216-241.","DOI":"10.1093\/toxsci\/kft176"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Nathwani, R.A. and Kaplowitz, N. (2006): Drug hepatotoxicity. Clin. Liver Dis., <b>10<\/b>, 207-217. vii.","DOI":"10.1016\/j.cld.2006.05.009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Navarro, V.J. and Senior, J.R. (2006): Drug-related hepatotoxicity. N. Engl. J. Med., <b>354<\/b>, 731-739.","DOI":"10.1056\/NEJMra052270"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Ogimura, E., Sekine, S. and Horie, T. (2011): Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes. Biochem. Biophys. Res. Commun., <b>416<\/b>, 313-317.","DOI":"10.1016\/j.bbrc.2011.11.032"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Ogimura, E., Tokizono, M., Sekine, S., Nakagawa, T., Bando, K. and Ito, K. (2017): Metabolic activation of cholestatic drug-induced bile acid-dependent toxicity in human sandwich-cultured hepatocytes. J. Pharm. Sci., <b>106<\/b>, 2509-2514.","DOI":"10.1016\/j.xphs.2017.04.050"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Oizumi, K., Sekine, S., Fukagai, M., Susukida, T. and Ito, K. (2017): Identification of bile acids responsible for inhibiting the bile salt export pump, leading to bile acid accumulation and cell toxicity in rat hepatocytes. J. Pharm. Sci., <b>106<\/b>, 2412-2419.","DOI":"10.1016\/j.xphs.2017.05.017"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Oorts, M., Baze, A., Bachellier, P., Heyd, B., Zacharias, T., Annaert, P. and Richert, L. (2016): Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes. Toxicol. In Vitro, <b>34<\/b>, 179-186.","DOI":"10.1016\/j.tiv.2016.03.008"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Parent, R., Marion, M.J., Furio, L., Tr\u00e9po, C. and Petit, M.A. (2004): Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology, <b>126<\/b>, 1147-1156.","DOI":"10.1053\/j.gastro.2004.01.002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Ramaiahgari, S.C., den Braver, M.W., Herpers, B., Terpstra, V., Commandeur, J.N., van de Water, B. and Price, L.S. (2014): A 3D <i>in vitro<\/i> model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies. Arch. Toxicol., <b>88<\/b>, 1083-1095.","DOI":"10.1007\/s00204-014-1215-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Sakai, Y., Iwao, T., Susukida, T., Nukaga, T., Takemura, A., Sekine, S., Ito, K. and Matsunaga, T. (2019a): In vitro bile acid-dependent hepatocyte toxicity assay system using human induced pluripotent stem cell-derived hepatocytes: current status and disadvantages to overcome. Drug Metab. Pharmacokinet., <b>34<\/b>, 264-271.","DOI":"10.1016\/j.dmpk.2019.04.004"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Sakai, Y., Okumura, H., Iwao, T., Watashi, K., Ito, K. and Matsunaga, T. (2019b): Development of an <i>in vitro<\/i> cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration. Toxicol. In Vitro, <b>61<\/b>, 104619.","DOI":"10.1016\/j.tiv.2019.104619"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Sundaram, V. and Bj\u00f6rnsson, E.S. (2017): Drug-induced cholestasis. Hepatol. Commun., <b>1<\/b>, 726-735.","DOI":"10.1002\/hep4.1088"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Scherer, M., Gnewuch, C., Schmitz, G. and Liebisch, G. (2009): Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., <b>877<\/b>, 3920-3925.","DOI":"10.1016\/j.jchromb.2009.09.038"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Sharanek, A., Burban, A., Burbank, M., Le Guevel, R., Li, R., Guillouzo, A. and Guguen-Guillouzo, C. (2016): Rho-kinase\/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs. Sci. Rep., <b>6<\/b>, 24709.","DOI":"10.1038\/srep24709"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Sharanek, A., Burban, A., Humbert, L., Guguen-Guillouzo, C., Rainteau, D. and Guillouzo, A. (2017): Progressive and preferential cellular accumulation of hydrophobic bile acids induced by cholestatic drugs is associated with inhibition of their amidation and sulfation. Drug Metab. Dispos., <b>45<\/b>, 1292-1303.","DOI":"10.1124\/dmd.117.077420"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Susukida, T., Sekine, S., Ogimura, E., Aoki, S., Oizumi, K., Horie, T. and Ito, K. (2015): Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes. Toxicol. In Vitro, <b>29<\/b>, 1454-1463.","DOI":"10.1016\/j.tiv.2015.06.004"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Susukida, T., Sekine, S., Nozaki, M., Tokizono, M., Oizumi, K., Horie, T. and Ito, K. (2016): Establishment of a drug-induced, bile acid-dependent hepatotoxicity model using HepaRG cells. J. Pharm. Sci., <b>105<\/b>, 1550-1560.","DOI":"10.1016\/j.xphs.2016.01.013"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Tomida, T., Okamura, H., Yokoi, T. and Konno, Y. (2017): A modified multiparametric assay using HepaRG cells for predicting the degree of drug-induced liver injury risk. J. Appl. Toxicol., <b>37<\/b>, 382-390.","DOI":"10.1002\/jat.3371"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Trottier, J., Bia\u0142ek, A., Caron, P., Straka, R.J., Heathcote, J., Milkiewicz, P. and Barbier, O. (2012): Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study. Dig. Liver Dis., <b>44<\/b>, 303-310.","DOI":"10.1016\/j.dld.2011.10.025"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Turpeinen, M., Tolonen, A., Chesne, C., Guillouzo, A., Uusitalo, J. and Pelkonen, O. (2009): Functional expression, inhibition and induction of CYP enzymes in HepaRG cells. Toxicol. In Vitro, <b>23<\/b>, 748-753.","DOI":"10.1016\/j.tiv.2009.03.008"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Van den Hof, W.F., Ruiz-Aracama, A., Van Summeren, A., Jennen, D.G., Gaj, S., Coonen, M.L., Brauers, K., Wodzig, W.K., van Delft, J.H. and Kleinjans, J.C. (2015): Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity <i>in vitro.<\/i> Toxicol. In Vitro, <b>29<\/b>, 489-501.","DOI":"10.1016\/j.tiv.2014.12.016"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Weber, S. and Gerbes, A.L. (2022): Challenges and future of drug-induced liver injury research-laboratory tests. Int. J. Mol. Sci., <b>23<\/b>, 6049.","DOI":"10.3390\/ijms23116049"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Weiss, J., Theile, D., Spalwisz, A., Burhenne, J., Riedel, K.D. and Haefeli, W.E. (2013): Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells. Biochem. Pharmacol., <b>85<\/b>, 265-273.","DOI":"10.1016\/j.bcp.2012.11.020"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Xu, J.J., Henstock, P.V., Dunn, M.C., Smith, A.R., Chabot, J.R. and de Graaf, D. (2008): Cellular imaging predictions of clinical drug-induced liver injury. Toxicol. Sci., <b>105<\/b>, 97-105.","DOI":"10.1093\/toxsci\/kfn109"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/48\/1\/48_47\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T04:28:37Z","timestamp":1673065717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/48\/1\/48_47\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.48.47","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}